AQXP - Aquinox Pharmaceuticals Inc.
Previous close
3.68
3.680 100.000%
Share volume: 0
Last Updated: Fri 09 Aug 2019 10:00:01 PM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
52%
Profitability
71%
Dept financing
2%
Liquidity
50%
Performance
45%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 30-Jun-2015 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.47%
Return on assets
-7.41%
Return on sales
0%
Return on invested capital
58.91%
Total debt ratio
7.32%
Debt ratio change over timeo
-1.08%
Current Ratio
17.08%
Quick Ratio
0%
Cash Position Ratio
11.67%
Short-term ratios 30-Jun-2018 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-7.34%
Return on assets
-4.83%
Return on sales
0%
Return on invested capital
84.4%
Total debt ratio
6.52%
Debt ratio change over timeo
-1.1%
Current Ratio
27.19%
Quick Ratio
0%
Cash Position Ratio
27.01%
Last quarter ratios 30-Jun-2019
The data are presented for the financials results of the last quarter.
Return on equity
-0%
Return on assets
-3.02%
Return on sales
0%
Return on invested capital
0.16%
Total debt ratio
1.92%
Debt ratio change over time
-0.97%
Current Ratio
63.17%
Quick Ratio
0%
Cash Position Ratio
62.73%
Performance ratios (change over 4 years) 30-Jun-2015 - 30-Jun-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-86.66%
Return on assets
-91.14%
Return on sales
0%
Return on invested capital
-91.01%
Total debt ratio
-108.37%
Debt ratio change over time
-1.08%
Current Ratio
-8.05%
Quick Ratio
0%
Cash Position Ratio
1.75%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | AQXP | IMMU | MNTA | ONCE |
---|---|---|---|---|
Return on equity | -8.47% | -5.61% | -10.5% | -11.67% |
Return on assets | -7.41% | -20.86% | -8.18% | -9.47% |
Return on sales | 0% | -5539.23% | 0% | -356.65% |
Return on invested capital | 58.91% | 354.56% | -245.62% | -123.06% |
Profitability | 54% | 50% | 0% | 0% |
Total debt ratio | 7.32% | 135.51% | 24.76% | 24.16% |
Debt ratio change over time | -1.08% | 0.12% | -1.08% | -1.38% |
Dept financing | 1% | 50% | 5% | 4% |
Current Ratio | 27.19% | 11.79% | 7.07% | 7.83% |
Quick Ratio | 0% | 0% | 0% | 7.46% |
Cash Position Ratio | 27.01% | 11.51% | 3.1% | 1.63% |
Liquididy | 50% | 28% | 15% | 45% |
Short-term ratios | AQXP | IMMU | MNTA | ONCE |
---|---|---|---|---|
Return on equity | -7.34% | -42.29% | -17.27% | -12.45% |
Return on assets | -4.83% | -16.67% | -11.14% | -7.48% |
Return on sales | 0% | 0% | 0% | -422.62% |
Return on invested capital | 84.4% | 675.1% | -305.46% | -38.28% |
Profitability | 78% | 25% | 0% | 0% |
Total debt ratio | 6.52% | 57.87% | 25.5% | 39.42% |
Debt ratio change over time | -1.1% | -0.87% | -1.62% | -1.81% |
Dept financing | 3% | 50% | 11% | 17% |
Current Ratio | 27.19% | 11.79% | 7.07% | 7.83% |
Quick Ratio | 0% | 0% | 0% | 7.46% |
Cash Position Ratio | 27.01% | 11.51% | 3.1% | 1.63% |
Liquididy | 50% | 21% | 9% | 34% |